Anti-Infectives, Photodisinfection
Total Trials
9
As Lead Sponsor
6
As Collaborator
3
Total Enrollment
10,391
NCT01854619
Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis
Phase: N/A
Role: Lead Sponsor
Start: May 31, 2013
Completion: Mar 31, 2014
NCT03270254
Photodynamic Therapy Plus Root Debridement in Gum Disease Treatment V2
Role: Collaborator
Start: Oct 13, 2017
Completion: Sep 19, 2018
NCT05184205
Photodynamic Therapy for COVID-19 Prevention
Start: Dec 20, 2021
Completion: May 30, 2022
NCT05090657
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
Phase: Phase 2
Start: Feb 4, 2022
Completion: Aug 6, 2022
NCT05797818
Red Light Photobiomodulation and Topical Disinfectants
Phase: Phase 1/2
Start: Jan 10, 2023
Completion: Feb 8, 2023
NCT06570252
Preoperative Microbial Reduction of the Nasal Cavity With Antimicrobial Photodynamic Therapy (aPDT).
Start: Oct 31, 2024
Completion: Aug 31, 2026
NCT06702878
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
Phase: Phase 3
Start: Dec 27, 2024
Completion: Aug 31, 2025
NCT06867458
Steriwave ICU Pilot Study
Start: Mar 31, 2025
Completion: Aug 4, 2025
NCT07189858
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada
Start: Oct 6, 2025
Completion: Dec 31, 2025
Loading map...